Entrepreneur News Network

Immuneel Therapeutics Raises ₹100 Crore in Series B Funding to Expand Cancer Cell Therapy Business

Immuneel Therapeutics

Indian biotechnology company Immuneel Therapeutics has secured ₹100 crore (approximately $10.5 million) in a Series B funding round, attracting participation from both new and existing investors as it accelerates the development and commercialization of advanced cancer therapies. The latest funding round saw investments from Singularity AMC, Rainmatter by Zerodha, and several high-net-worth individuals. Existing backers … Read more

Cellogen Therapeutics Raises ₹20 Crore to Advance CAR-T Cancer Therapy and Gene Research

Cellogen Therapeutics

Delhi-based Cellogen Therapeutics, a biotechnology startup focused on cell and gene therapy, has raised ₹20 crore (approximately $2 million) in funding from Kotak Alternate Asset Managers. The fresh investment will support the company’s efforts to accelerate development of advanced CAR-T cancer therapies, strengthen gene therapy research programs, and scale manufacturing capabilities. Funding to Support CAR-T … Read more